ClassID:

21647

A61K2300/00 - page 86 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#25501
20050053611
2005-03-10

Pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug

#25502
20050053597
2005-03-10

Composition and method for treatment of wounds

#25503
20050053596
2005-03-10

Therapeutic biological product and method for formation of new vascularised bone

#25504
20050053595
2005-03-10

Composition for topical treatment

#25505
20050053572
2005-03-10

Composition for promoting hair growth

#25506
20050053560
2005-03-10

Use of a composition containing extracts of Vitis vinifera and lycopersicum for protecting the skin

#25507
20050053558
2005-03-10

Sleep inducing toothpaste made with natural herbs and a natural hormone

#25508
20050053555
2005-03-10

Appetite control compositions and methods of use

#25509
20050053553
2005-03-10

Combined doses of formoterol and fluticasone

#25510
20050053548
2005-03-10

Use of collagenase to facilitate guide wire crossing in total arterial occlusions

#25511
20050053516
2005-03-10

Anti-pathogenic composition useful in blood preservation

#25512
20050051922
2005-03-10

Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same

#25513
20050051483
2005-03-10

Process for preparing water soluble diterpenes and their applications

#25514
20050049305
2005-03-03

Use of L-carnitine in the prevention and treatment of hearing loss

#25515
20050049298
2005-03-03

Production of Δ 9 tetrahydrocannabinol

#25516
20050049293
2005-03-03

Use of cholinesterase antagonists to treat insulin resistance

#25517
20050049255
2005-03-03

Therapeutic combinations

#25518
20050049243
2005-03-03

Pharmaceutical composition comprising an AChE inhibitor and a mGluR2 antagonist

#25519
20050049233
2005-03-03

Method for treating erectile dysfunction and increasing libido in men

#25520
20050049229
2005-03-03

Therapeutic applications of 2-hydroxyacetanilide

#25521
20050049225
2005-03-03

Use of bisphosphonates for otosclerosis

#25522
20050049224
2005-03-03

Antimicrobial mixtures comprising iodopropynyl compounds and dimethyldithiocarbamate derivatives

#25523
20050049220
2005-03-03

Dosing regimen for Flaviviridae therapy

#25524
20050049195
2005-03-03

Methods and compositions for nerve regeneration

#25525
20050048148
2005-03-03

Compositions comprising thylakoids useful in the modulation of inflammation process

#25526
20050048146
2005-03-03

Therapeutic composition providing enhanced cardiac function

#25527
20050048143
2005-03-03

Antioxidant compositions and methods thereto

#25528
20050048140
2005-03-03

Topical compositions having a natural ingredient and method of use

#25529
20050048136
2005-03-03

Rehydrating beverage with Rhodiola crenulata and D-ribose that enhances blood oxygen and relieves post-exertional muscle cramping and soreness

#25530
20050048130
2005-03-03

Therapeutic composition providing respiratory relief

#25531
20050048129
2005-03-03

Methods and compositions to aid breast enhancement

#25532
20050048128
2005-03-03

Process for producing collagen production enhancers and use thereof

#25533
20050048125
2005-03-03

Glycoprotein matrix compositions and methods related thereto

#25534
20050048124
2005-03-03

Antimicrobial composition for medical articles

#25535
20050048120
2005-03-03

Dosage form comprising self-destructive membrane

#25536
20050048119
2005-03-03

Controlled release composition with semi-permeable membrane and poloxamer flux enhancer

#25537
20050048107
2005-03-03

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

#25538
20050048106
2005-03-03

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

#25539
20050048050
2005-03-03

Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth

#25540
20050048049
2005-03-03

Prevention and treatment of amyloidogenic disease

#25541
20050048035
2005-03-03

Methods of using regenerative cells in the treatment of stroke and related diseases and disorders

#25542
20050048034
2005-03-03

Methods of using adipose derived stem cells to promote wound healing

#25543
20050048031
2005-03-03

Defective recombinant adenoviruses expressing cytokines for antitumor treatment

#25544
20050043787
2005-02-24

Medical device with coating that promotes endothelial cell adherence

#25545
20050043773
2005-02-24

Methods of improving the safety of zonisamide therapy

#25546
20050043705
2005-02-24

Methods of using zonisamide as an adjunctive therapy for partial seizures

#25547
20050043704
2005-02-24

Methods of using zonisamide as an adjunctive therapy for partial seizures

#25548
20050043413
2005-02-24

Active ingredient for producing a substance containing isocitrate for influencing the coagulation tendency of blood

#25549
20050043412
2005-02-24

Remedies for glaucoma comprising bunazosin and prostaglandins

#25550
20050043409
2005-02-24

Combinations comprising a selective cyclooxygenase-2 inhibitor

#25551
20050043407
2005-02-24

Pharmaceutical composition for the prevention and treatment of addiction in a mammal

#25552
20050043406
2005-02-24

Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss

#25553
20050043400
2005-02-24

Oral composition to reduce cold symptoms and duration of same

#25554
20050043399
2005-02-24

Dimeric compounds and their use as anti-viral agents

#25555
20050043398
2005-02-24

Use of chromen-4-one derivatives

#25556
20050043395
2005-02-24

Combination therapy comprising zd6474 and a taxane

#25557
20050043394
2005-02-24

Pharmaceutically active uridine esters

#25558
20050043391
2005-02-24

Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome

#25559
20050043383
2005-02-24

Combined agents for treatment of glaucoma

#25560
20050043376
2005-02-24

Synthesis of epothilones, intermediates thereto, analogues and uses thereof

#25561
20050043369
2005-02-24

Bactericidal antimicrobial methods and compositions for use in treating gram positive infections

#25562
20050043367
2005-02-24

Methods to mobilize progenitor/stem cells

#25563
20050043346
2005-02-24

Pyridylpyrrole derivatives active as kinase inhibitors

#25564
20050043345
2005-02-24

Pharmaceutical composition for the prevention and treatment of addiction in a mammal

#25565
20050043343
2005-02-24

Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor

#25566
20050043327
2005-02-24

Pharmaceutical composition for the prevention and treatment of addiction in a mammal

#25567
20050043323
2005-02-24

Pyrimidylpyrrole derivatives active as kinase inhibitors

#25568
20050043321
2005-02-24

Method for treating atopic disorders

#25569
20050043312
2005-02-24

Formulations for reducing neuronal degeneration

#25570
20050043287
2005-02-24

Composition comprising L-arginine as a muscle growth stimulant and use thereof

#25571
20050043274
2005-02-24

Pharmaceutical compositions and methods for lowering blood pressure and pulse rate

#25572
20050043271
2005-02-24

Heparin-containing ophthalmic agent

#25573
20050043269
2005-02-24

Pharmaceutically active uridine esters

#25574
20050043258
2005-02-24

Methods of treating xerostomia and xerophthalmia

#25575
20050043251
2005-02-24

Method of treatment of otitis externa

#25576
20050043240
2005-02-24

Methods of reducing visceral fat by increasing levels of insulin-like growth factor-I (IGF-I)

#25577
20050043238
2005-02-24

Exendins and exendin agonists for weight reduction and obesity

#25578
20050043235
2005-02-24

Use of VEGF-C or VEGF-D in reconstructive surgery

#25579
20050043233
2005-02-24

Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis

#25580
20050043231
2005-02-24

Therapy for growth hormone induced insulin resistance in juveniles with growth disorders

#25581
20050043230
2005-02-24

Use of long pentraxin ptx3 for the treatment of fgf-8 mediated tumour diseases

#25582
20050043228
2005-02-24

GLP-1 formulations with protracted time action

#25583
20050043222
2005-02-24

Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application

#25584
20050043218
2005-02-24

Inhibitor of stem cell proliferation and uses thereof

#25585
20050043217
2005-02-24

Stabilized compositions containing an oxygen-labile active agent and lactoglobulin

#25586
20050043214
2005-02-24

Antiglaucomatous agent and use thereof

#25587
20050043212
2005-02-24

Differential inhibition of p38 map kinase isoforms

#25588
20050042690
2005-02-24

Diagnosis and management of infection caused by chlamydia

#25589
20050042354
2005-02-24

Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals

#25590
20050042347
2005-02-24

Method of producing an oil extract from seeds of plants via a binary azeotropic solvent mixture

#25591
20050042317
2005-02-24

Complex mixtures exhibiting selective inhibition of cyclooxygenase-2

#25592
20050042315
2005-02-24

Plant extracts for the treatment of increased bone resorption

#25593
20050042312
2005-02-24

Solubility and Absorption Promoter

#25594
20050042309
2005-02-24

Stabilized compositions containing an oxygen-labile active agent and a plant extract

#25595
20050042308
2005-02-24

Pharmaceutical composition having cholagogic and litholytic effect and its preparation method

#25596
20050042306
2005-02-24

Stabilized compositions containing an oxygen-labile active agent

#25597
20050042304
2005-02-24

Novel substituted benzimidazole dosage forms and method of using same

#25598
20050042303
2005-02-24

Therapeutic protocols

#25599
20050042295
2005-02-24

Anti-angiogenic compositions and methods of use

#25600
20050042283
2005-02-24

Histamine and CCK2/gastrin receptor blockade in the treatment of acid-peptic disease and cancer

#25601
20050042271
2005-02-24

Transdermal delivery system for alkaloids of aconitum species

#25602
20050042268
2005-02-24

Pharmaceutical composition and method for transdermal drug delivery

#25603
20050042256
2005-02-24

Lipid blends and food products containing oleic fatty acid and omega-6 fatty acids, designed to increase the intramyocellular lipid level

#25604
20050042252
2005-02-24

Regulation of biodegradability of composite biomaterials

#25605
20050042249
2005-02-24

Warming and nonirritating lubricant compositions and method of comparing irritation

#25606
20050042248
2005-02-24

Warming and nonirritating lubricant compositions and method of comparing irritation

#25607
20050042241
2005-02-24

Dr. Bob's Arthritis Cream

#25608
20050042236
2005-02-24

Plant extract active as an immunostimulating agent

#25609
20050042233
2005-02-24

Stabilized compositions containing an oxygen-labile active agent and a fungal extract

#25610
20050042228
2005-02-24

Method and pharmaceutical composition for the treatment of immune disorders

#25611
20050042224
2005-02-24

Methods and products related to metabolic interactions in disease

#25612
20050042220
2005-02-24

Monoclonal antibodies against interleukin-22

#25613
20050042219
2005-02-24

Engineered Fab' fragment anti-tumor necrosis factor alpha in combination with disease modifying anti-rheumatic drugs

#25614
20050042215
2005-02-24

Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound

#25615
20050042210
2005-02-24

Body tissue filling material, production method thereof and body tissue filler

#25616
20050042202
2005-02-24

Compositions for and methods of treating and preventing sirs/sepsis

#25617
20050042201
2005-02-24

Histidine-rich glycoprotein

#25618
20050042198
2005-02-24

Method for rendering a contact lens wettable

#25619
20050042186
2005-02-24

All natural sunscreen lotion

#25620
20050042182
2005-02-24

Topical compositions of urea

#25621
20050042176
2005-02-24

Medicaments for inhalation comprising a novel anticholinergic and a steroid

#25622
20050042171
2005-02-24

Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma

#25623
20050042170
2005-02-24

Method and device for generating mists and medical uses thereof

#25624
20050038270
2005-02-17

Methods for producing sterol ester-rich compositions

#25625
20050038233
2005-02-17

Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use

#25626
20050038126
2005-02-17

Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome

#25627
20050038122
2005-02-17

Phenyl naphthol ligands for thyroid hormone receptor

#25628
20050038116
2005-02-17

Novel class of compounds (Choline derivatives, esp. Stearyl Choline Cloride and other salts) for the treatment of Alzheimer's disease, Down syndrome and central (and/or peripheral) nervous system and memory related disorders or for enhancements

#25629
20050038113
2005-02-17

Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual disease

#25630
20050038102
2005-02-17

Upregulation of type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors

#25631
20050038083
2005-02-17

Combination of phenylcarboxamides with blockers of the IKr channel and their use for the treatment of atrial arrhythmias

#25632
20050038063
2005-02-17

Method of treating acute pain with unitary dosage form comprising ibuprofen and oxycodone

#25633
20050038062
2005-02-17

Methods and materials for the treatment of pain comprising opioid antagonists

#25634
20050038046
2005-02-17

Synergistic enhancement of cognitive ability

#25635
20050038044
2005-02-17

Use of propionyl-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease

#25636
20050038029
2005-02-17

Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs

#25637
20050038019
2005-02-17

Hydroxy substituted amides for the treatment of alzheimer's disease

#25638
20050038018
2005-02-17

Meloxicam compositions

#25639
20050038017
2005-02-17

Method and composition for restoring diuretic and renal function

#25640
20050038008
2005-02-17

Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug

#25641
20050038007
2005-02-17

Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors

#25642
20050038006
2005-02-17

Triphasic oral contraceptive

#25643
20050038004
2005-02-17

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

#25644
20050038001
2005-02-17

Transdiscal administration of cycline compounds

#25645
20050037998
2005-02-17

Enhancement of magnesium uptake in mammals

#25646
20050037993
2005-02-17

Bulking agents as satiety agents

#25647
20050037992
2005-02-17

Composition and method for treating neurological disorders

#25648
20050037983
2005-02-17

Compositions and methods for the treatment of depression and other affective disorders

#25649
20050037961
2005-02-17

Smooth muscle cell differentiation with CRP, SRF and GATA factors

#25650
20050037130
2005-02-17

Method and compositions for producing berry derived products

#25651
20050037100
2005-02-17

Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic

#25652
20050037095
2005-02-17

Compositions enriched in anthocyanins

#25653
20050037094
2005-02-17

Composition for heart disease, its active ingredients, method to prepare same and uses thereof

#25654
20050037092
2005-02-17

Vascularization therapy by highly concentrated carbonated warm water bath

#25655
20050037090
2005-02-17

Combination therapy including a cyclooxygenase-2 inhibitor and an antineoplastic agent

#25656
20050037089
2005-02-17

Method for promoting bone growth

#25657
20050037070
2005-02-17

Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them

#25658
20050037066
2005-02-17

Formulation and manufacturing process for Coenzyme Q10 soft gel capsules

#25659
20050037065
2005-02-17

NUTRITIONAL FORMULATIONS

#25660
20050037062
2005-02-17

Emulsifying systems containing azetidine derivatives

#25661
20050037040
2005-02-17

Topical compositions of urea and ammonium lactate

#25662
20050037039
2005-02-17

Composition for treatment of tinea pedis and method of use

#25663
20050037026
2005-02-17

Prevention and treatment of amyloidogenic disease

#25664
20050037025
2005-02-17

Methods and compositions comprising kava and mate' or theobromine

#25665
20050037018
2005-02-17

HCV combination therapy

#25666
20050037008
2005-02-17

Methods of inhibiting TNFα in patients with cancer

#25667
20050037007
2005-02-17

Methods for treating conditions associated with the accumulation of excess extracellular matrix

#25668
20050036998
2005-02-17

Formulation and manufacturing process for Coenzyme Q10 soft gel capsules

#25669
20050036995
2005-02-17

Genetic vaccines for cancer therapy

#25670
20050036994
2005-02-17

Compounds and methods for downregulating the effects of TGF-beta

#25671
20050036991
2005-02-17

Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof

#25672
20050036981
2005-02-17

USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY

#25673
20050036963
2005-02-17

Compositions and methods for treating skin conditions

#25674
20050036953
2005-02-17

Topical compositions of ammonium lactate

#25675
20050036952
2005-02-17

Compositions and methods for the treatment of aches and pains

#25676
20050033261
2005-02-10

Drug/drug delivery systems for the prevention and treatment of vascular disease

#25677
20050033059
2005-02-10

Synthesis of epothilones, intermediates thereto, analogues and uses thereof

#25678
20050033051
2005-02-10

Nucleosides preparation thereof and use as inhibitors of rna viral polymerases

#25679
20050033034
2005-02-10

ANTI-T CELL IMMUNOTOXIN FUSION PROTEIN AND ITS THERAPEUTIC USE

#25680
20050032914
2005-02-10

Lutein/zeaxanthin for glare protection

#25681
20050032904
2005-02-10

Composition and use of allylamine derivatives

#25682
20050032899
2005-02-10

Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination

#25683
20050032895
2005-02-10

Medicament for the treatment of viral skin and tumour diseases

#25684
20050032893
2005-02-10

Biodegradable penetration enhancers with multiple hydrophilic moieties

#25685
20050032892
2005-02-10

Compositions, kits, and methods for treating gastrointestinal conditions

#25686
20050032890
2005-02-10

Aniline-derived ligands for the thyroid receptor

#25687
20050032882
2005-02-10

Botanical extract compositions and methods of use

#25688
20050032879
2005-02-10

Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases

#25689
20050032878
2005-02-10

Oral pharmaceutical composition containing a combination pparalpha and a hmg-coa reductase inhibitor

#25690
20050032876
2005-02-10

Pharmaceutical compositions comprising sumatriptan and metoclopramide, and methods of use thereof

#25691
20050032841
2005-02-10

Therapeutic compositions and methods of treating glycolipid storage related disorders

#25692
20050032840
2005-02-10

Novel therapeutic use of a thienylcyclohexylamine derivative

#25693
20050032815
2005-02-10

Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants

#25694
20050032801
2005-02-10

Compositions containing a ruthenium(III) complex and a heterocycle

#25695
20050032784
2005-02-10

Combination drug therapy for treating hypertension

#25696
20050032783
2005-02-10

Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients

#25697
20050032780
2005-02-10

Method of treating functional bowel disorders

#25698
20050032774
2005-02-10

Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity

#25699
20050032773
2005-02-10

Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity

#25700
20050032761
2005-02-10

Lipid profile modulation

#25701
20050032759
2005-02-10

Antitumor combined therapy

#25702
20050032758
2005-02-10

Hormone replacement therapy and depression

#25703
20050032757
2005-02-10

Nutritional supplements

#25704
20050032756
2005-02-10

Multistage preparation for contraception based on natural estrogens

#25705
20050032753
2005-02-10

Substituted phenol compounds useful for anesthesia and sedation

#25706
20050032751
2005-02-10

Methods for treatment of dermatological conditions

#25707
20050032743
2005-02-10

Compositions and method for steroid homeostasis

#25708
20050032741
2005-02-10

Vitamin Compositions

#25709
20050032740
2005-02-10

Vitamin compositions for the treatment and prevention of vascular disease and dementia

#25710
20050032738
2005-02-10

Method of treating cancer by conjunctive therapy with 2'-haloemethylidene derivatives and a S-phase or M-phase specific antineoplastic agent

#25711
20050032730
2005-02-10

Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions

#25712
20050032721
2005-02-10

Methods of administering dalbavancin for treatment of skin and soft tissue infections

#25713
20050032719
2005-02-10

Anthelmintic formulations

#25714
20050032718
2005-02-10

Anthelmintic formulations

#25715
20050032715
2005-02-10

Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds

#25716
20050032714
2005-02-10

Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers

#25717
20050032713
2005-02-10

Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents

#25718
20050032703
2005-02-10

Method of preparation of stabilized thrombin-activatable fibrinolysis inhibitor (TAFI) and methods of use thereof

#25719
20050032699
2005-02-10

Method of treating cancer with a VEGF antagonist and an anti-proliferative agent

#25720
20050032698
2005-02-10

Stabilized formulation of parathyroid hormone

#25721
20050032691
2005-02-10

Methods for treating glaucoma

#25722
20050032690
2005-02-10

Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia

#25723
20050032685
2005-02-10

Remedies for bone loss

#25724
20050032674
2005-02-10

SAIF, an anti-inflammatory factor, and methods of use thereof

#25725
20050031737
2005-02-10

Antioxidative compositions

#25726
20050031718
2005-02-10

Sea Buckthorn compositions and associated methods

#25727
20050031716
2005-02-10

Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer

#25728
20050031712
2005-02-10

Agent for suppressing or preventing gastralgia, and composition for food or beverage

#25729
20050031711
2005-02-10

Method for processing ginseng and the uses of extract of processed ginseng

#25730
20050031709
2005-02-10

Novel composition containing extracts of butyrospermum parkii and the use of such a composition for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity or pain

#25731
20050031708
2005-02-10

Composition comprising a zeolite compound for treatment of diseases

#25732
20050031706
2005-02-10

Viscosity-stable compositions useful for treating gastrointestinal disorders

#25733
20050031704
2005-02-10

Tricalcium phosphates, their composites, implants incorporating them, and method for their production

#25734
20050031694
2005-02-10

Methods for promoting growth of bone, ligament, and cartilage using zvegf4

#25735
20050031692
2005-02-10

Spray drying processes for forming solid amorphous dispersions of drugs and polymers

#25736
20050031685
2005-02-10

Pharmaceutical composition for controlled release of a beta-lactam antibiotic

#25737
20050031681
2005-02-10

Formulation and manufacturing process for Coenzyme Q10 soft gel capsules

#25738
20050031629
2005-02-10

Prevention and treatment of amyloidogenic disease

#25739
20050031620
2005-02-10

Combined cancer treatment methods using selected antibodies to aminophospholipids

#25740
20050031611
2005-02-10

Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis

#25741
20050031606
2005-02-10

Lyase treatment for

#25742
20050031605
2005-02-10

Compositions and methods of treating diabetes

#25743
20050031601
2005-02-10

Composition comprising a strain and uses thereof

#25744
20050031594
2005-02-10

Pharmaceutical composition for treatment of cancers

#25745
20050031591
2005-02-10

Tumor-specific promotor and use thereof

#25746
20050031589
2005-02-10

Method of treating hepatitis C infection

#25747
20050031588
2005-02-10

2′-branched nucleosides and Flaviviridae mutation

#25748
20050031587
2005-02-10

Immune response induction method

#25749
20050031586
2005-02-10

Method for treating hepatitis c virus infection in treatment failure patients

#25750
20050031585
2005-02-10

Method for treating hepatitis c virus infection in treatment failure patients

#25751
20050031557
2005-02-10

Oral administration of beta-carotene, lycopene and lutein for human skin protection

#25752
20050028228
2005-02-03

Acellular tissue matrices made from alpa-1,3-galactose-deficient tissue

#25753
20050027019
2005-02-03

Aqueous 2,6-diisopropylphenol pharmaceutical compositions

#25754
20050027005
2005-02-03

Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner

#25755
20050027004
2005-02-03

Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions

#25756
20050027003
2005-02-03

Methods of therapeutic treatment using retinoids with reduced side effects

#25757
20050027000
2005-02-03

Methods and compounds useful to induce apoptosis in cancer cells

#25758
20050026996
2005-02-03

Taxane prodrugs

#25759
20050026992
2005-02-03

Treatment and prevention of cardiovascular events

#25760
20050026986
2005-02-03

Use of central cannabinoid receptor antagonists for the preparation of drugs

#25761
20050026982
2005-02-03

Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient

#25762
20050026979
2005-02-03

Methods for treating inflammation and inflammation-associated diseases with a statin and ether

#25763
20050026977
2005-02-03

Zonisamide use in eating disorders

#25764
20050026961
2005-02-03

Analgesic and anti-inflammatory compositions comprising domperidone and methods of using the same

#25765
20050026957
2005-02-03

Methods of treating nodulocystic acne

#25766
20050026951
2005-02-03

Methods of therapeutic treatment using retinoids with reduced drug interaction

#25767
20050026948
2005-02-03

Medicaments for inhalation comprising an anticholinergic and a betamimetic

#25768
20050026924
2005-02-03

Compositions containing alpha-2-adrenergic agonist components

#25769
20050026909
2005-02-03

Method of treating lower urinary tract disorders

#25770
20050026898
2005-02-03

Semi-solid systems containing azetidine derivatives

#25771
20050026892
2005-02-03

Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application

#25772
20050026891
2005-02-03

Progesterone receptor modulators with increased antigonadotropic activity for female birth control and hormone replacement therapy

#25773
20050026890
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease

#25774
20050026887
2005-02-03

Medicaments for inhalation comprising an anticholinergic and a steroid

#25775
20050026886
2005-02-03

Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor

#25776
20050026884
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease

#25777
20050026883
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease

#25778
20050026882
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease

#25779
20050026881
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease

#25780
20050026879
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease

#25781
20050026871
2005-02-03

Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative

#25782
20050026870
2005-02-03

Use of bisphosphonates for the treatment of osteogenesis imperfecta

#25783
20050026867
2005-02-03

Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain

#25784
20050026866
2005-02-03

Agents and methods for treatment of disease by oligosaccharide targeting agents

#25785
20050026852
2005-02-03

Method of augmenting the antitumor activity of anticancer agents

#25786
20050026850
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease

#25787
20050026849
2005-02-03

Water soluble formulations of digitalis glycosides for treating cell-proliferative and other diseases

#25788
20050026848
2005-02-03

Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease

#25789
20050026847
2005-02-03

Methods for treating, preventing, or inhibiting injuries, cell membrane stabilization, and calcium mobilization using pseudopterosin compounds

#25790
20050026846
2005-02-03

Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism

#25791
20050026842
2005-02-03

Compositions of Alpha3beta4 Receptor antagonists and opioid agonist analgesics

#25792
20050026835
2005-02-03

Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators

#25793
20050026819
2005-02-03

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

#25794
20050026815
2005-02-03

Recombinant human alpha-fetoprotein as an immunosuppressive agent

#25795
20050026229
2005-02-03

PSCA antibodies and hybridomas producing them

#25796
20050025847
2005-02-03

Microbicidal compositions and method of use

#25797
20050025846
2005-02-03

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

#25798
20050025845
2005-02-03

Standardized extracts of

#25799
20050025843
2005-02-03

Herbal pharmaceutical composition for treatment of cardiovascular disease

#25800
20050025841
2005-02-03

Therapeutic methods using herbal compositions